Jaking Tang

Dr. Jaking Tang, Co-Founder and CEO of NEOrgan, holds the core IP powering the next-generation Organ-on-a-Chip (OoC 4.0). Leveraging NEOrgan's organ-on-the chip expertise , Jaking drives NEOrgan's commercial strategy to solve pharma's $270M+ per-drug clinical failure problem. He is actively securing Big Pharma pilots for NEOrgan’s validated, high-throughput cardiotoxicity CRO services , delivering the industrial scale and structural fidelity required to de-risk drug discovery.